These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 12603815)

  • 21. Mental retardation and associated neurological dysfunctions in Down syndrome: a consequence of dysregulation in critical chromosome 21 genes and associated molecular pathways.
    Rachidi M; Lopes C
    Eur J Paediatr Neurol; 2008 May; 12(3):168-82. PubMed ID: 17933568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Down syndrome: the brain in trisomic mode.
    Dierssen M
    Nat Rev Neurosci; 2012 Dec; 13(12):844-58. PubMed ID: 23165261
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: challenging the gene dosage effect hypothesis (Part III).
    Cheon MS; Kim SH; Ovod V; Kopitar Jerala N; Morgan JI; Hatefi Y; Ijuin T; Takenawa T; Lubec G
    Amino Acids; 2003; 24(1-2):127-34. PubMed ID: 12624744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: challenging the gene dosage effect hypothesis (Part I).
    Cheon MS; Kim SH; Yaspo ML; Blasi F; Aoki Y; Melen K; Lubec G
    Amino Acids; 2003; 24(1-2):111-7. PubMed ID: 12624742
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A young child with trisomy 21. Medical aspects: myths and reality].
    Maurel Ollivier A
    Ann Pediatr (Paris); 1990 Oct; 37(8):515-7, 528. PubMed ID: 2148253
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mental retardation in Down syndrome: from gene dosage imbalance to molecular and cellular mechanisms.
    Rachidi M; Lopes C
    Neurosci Res; 2007 Dec; 59(4):349-69. PubMed ID: 17897742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary and secondary transcriptional effects in the developing human Down syndrome brain and heart.
    Mao R; Wang X; Spitznagel EL; Frelin LP; Ting JC; Ding H; Kim JW; Ruczinski I; Downey TJ; Pevsner J
    Genome Biol; 2005; 6(13):R107. PubMed ID: 16420667
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Normalizing the gene dosage of Dyrk1A in a mouse model of Down syndrome rescues several Alzheimer's disease phenotypes.
    García-Cerro S; Rueda N; Vidal V; Lantigua S; Martínez-Cué C
    Neurobiol Dis; 2017 Oct; 106():76-88. PubMed ID: 28647555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trisomy for the Down syndrome 'critical region' is necessary but not sufficient for brain phenotypes of trisomic mice.
    Olson LE; Roper RJ; Sengstaken CL; Peterson EA; Aquino V; Galdzicki Z; Siarey R; Pletnikov M; Moran TH; Reeves RH
    Hum Mol Genet; 2007 Apr; 16(7):774-82. PubMed ID: 17339268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mouse models of cognitive disabilities in trisomy 21 (Down syndrome).
    Roubertoux PL; Carlier M
    Am J Med Genet C Semin Med Genet; 2010 Nov; 154C(4):400-16. PubMed ID: 20981769
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anomalous brain morphology on magnetic resonance images in Williams syndrome and Down syndrome.
    Jernigan TL; Bellugi U
    Arch Neurol; 1990 May; 47(5):529-33. PubMed ID: 2139774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: Challenging the gene dosage effect hypothesis (Part IV).
    Cheon MS; Shim KS; Kim SH; Hara A; Lubec G
    Amino Acids; 2003 Jul; 25(1):41-7. PubMed ID: 12836057
    [TBL] [Abstract][Full Text] [Related]  

  • 33. On dendrites in Down syndrome and DS murine models: a spiny way to learn.
    Benavides-Piccione R; Ballesteros-Yáñez I; de Lagrán MM; Elston G; Estivill X; Fillat C; Defelipe J; Dierssen M
    Prog Neurobiol; 2004 Oct; 74(2):111-26. PubMed ID: 15518956
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alterations of brain circuits in Down syndrome murine models.
    Gotti S; Caricati E; Panzica G
    J Chem Neuroanat; 2011 Dec; 42(4):317-26. PubMed ID: 21946025
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Similarities and dissimilarities in the waking EEG of three types of mental retardation.
    Psatta DM; Christodorescu D
    Neurol Psychiatr (Bucur); 1981; 19(3):183-96. PubMed ID: 6459638
    [No Abstract]   [Full Text] [Related]  

  • 36. The triple risk hypotheses in sudden infant death syndrome.
    Guntheroth WG; Spiers PS
    Pediatrics; 2002 Nov; 110(5):e64. PubMed ID: 12415070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phenotypic variability in fetuses with down syndrome: a case-control pathological evaluation.
    Ramalho C; Brandão O; Matias A; Montenegro N
    Fetal Diagn Ther; 2011; 30(3):207-14. PubMed ID: 21952468
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Down syndrome cell adhesion molecule is conserved in mouse and highly expressed in the adult mouse brain.
    Barlow GM; Micales B; Lyons GE; Korenberg JR
    Cytogenet Cell Genet; 2001; 94(3-4):155-62. PubMed ID: 11856873
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prenatal pharmacotherapy rescues brain development in a Down's syndrome mouse model.
    Guidi S; Stagni F; Bianchi P; Ciani E; Giacomini A; De Franceschi M; Moldrich R; Kurniawan N; Mardon K; Giuliani A; Calzà L; Bartesaghi R
    Brain; 2014 Feb; 137(Pt 2):380-401. PubMed ID: 24334313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An Integrated Human/Murine Transcriptome and Pathway Approach To Identify Prenatal Treatments For Down Syndrome.
    Guedj F; Pennings JL; Massingham LJ; Wick HC; Siegel AE; Tantravahi U; Bianchi DW
    Sci Rep; 2016 Sep; 6():32353. PubMed ID: 27586445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.